Indian-origin scientist spots genes that fight Covid infection
- A group of scientists at Sanford Burnham Prebys Medical Discovery Institute have gained new insights into how the virus exploits the human cells it invades.
- The team of researchers are led by Sumit K. Chanda, professor and director of the Immunity and Pathogenesis Programme.
- Check out the latest news and updates on Business Insider.
According to Sumit K. Chanda, professor and director of the Immunity and Pathogenesis Programme at Sanford Burnham Prebys Medical Discovery Institute, the scientists have gained new insights into how the virus exploits the human cells it invades.
TOP VIDEOS FOR YOU"We are still searching for its Achille's Heel so that we can develop optimal antivirals," Chanda said in a paper published in the journal Molecular Cell.
AdvertisementKnowing which genes help control viral infection can greatly assist researchers' understanding of factors that affect disease severity and also suggest possible therapeutic options.
The genes in question are related to interferons, the body's frontline virus fighters.
Soon after the start of the pandemic, clinicians found that a weak interferon response to SARS-CoV-2 infection resulted in some of the more severe cases of Covid-19.
This knowledge led Chanda and his collaborators to search for the human genes that are triggered by interferons, known as interferon-stimulated genes (ISGs), which act to limit SARS-CoV-2 infection.
"We found that 65 ISGs controlled SARS-CoV-2 infection, including some that inhibited the virus' ability to enter cells, some that suppressed manufacture of the RNA that is the virus's lifeblood, and a cluster of genes that inhibited assembly of the virus," Chanda explained.
"What was also of great interest was the fact that some of the ISGs exhibited control across unrelated viruses, such as seasonal flu, West Nile and HIV, which leads to AIDS".
AdvertisementThe team also identified eight ISGs that inhibited both SARS-CoV-1 and CoV-2 replication in the subcellular compartment responsible for protein packaging, suggesting this vulnerable site could be exploited to clear viral infection.
"This is important information, but we still need to learn more about the biology of the virus and investigate if genetic variability within these ISGs correlates with Covid-19 severity," said Laura Martin-Sancho, a senior postdoctoral associate in the Chanda lab.
As a next step, the researchers will look at the biology of SARS-CoV-2 variants that continue to evolve and threaten vaccine efficacy.
Facebook’s Oversight Board has over 9,000 responses in the case related to Donald Trump’s suspension from the platform— a decision is coming soon
Thousands of IGCSE students are anxiously awaiting clarity on board exams set to start on April 27
How to bake a meteorite — scientists are heating up space rocks to recreate the birth of planets
- Cyber security jobs: Big companies like Apple, Microsoft, Intel, TCS are hiring professionals
- SBI, Airtel, Adani Enterprises, TCS and other top stocks to watch out for on August 4
- Krsnaa Diagnostics IPO opens—here is all you need to know
- These are some of the highest paid founders of Indian startups tapping capital markets this year
- Exxaro Tiles IPO opens today—here’s how to apply for IPO, check allotment status, listing date and more